ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

347
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
17 Feb 2020 11:02

SH/SZ Connect Flows: Moutai, Shanghai Intl Airport, Wuxi AppTec

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
227 Views
Share
11 Feb 2020 00:32

InnoCare Pharma IPO Initiation: Promising Prognosis

InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
383 Views
Share
bullishKingsoft Corp
06 Feb 2020 09:25

Kingsoft Stub Trade: Record Low Since Office Software Listing

We highlight that the stub value of Kingsoft (3888 HK) reached a record low since the listing of its main subsidiary Beijing Kingsoft (A) (Office...

Logo
498 Views
Share
23 Jan 2020 10:32

Long Pharmaron/Short Wuxi: Take Profit Now, A-Share Pullback the Key Risk

Pharmaron, the second-largest contract research organization (CRO) in China, was listed in Hong Kong on November 28th. The deal was anchored by a...

Logo
435 Views
Share
bearishWuxi Biologics
09 Jan 2020 20:39

WuXi Biologics Placement: Pushing the Limits

Wuxi Biologics (Cayman) Inc (2269 HK) is a global one-stop biologics services provider and often referred to as CRO (contract research...

Logo
465 Views
Share
x